TrkB inhibition as a therapeutic target for CNS-related disorders

Fabien Boulle, Gunter Kenis*, Maxime Cazorla, Michel Hamon, Harry W. M. Steinbusch, Laurence Lanfumey, Daniel L. A. van den Hove

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)197-206
JournalProgress in Neurobiology
Volume98
Issue number2
DOIs
Publication statusPublished - Aug 2012

Keywords

  • BDNF
  • Cancer
  • CNS disorders
  • TrkB inhibitors
  • Treatments

Cite this